COVID-19 Vaccine Allocation - Public Listening Session & Comment Period

Public Comment Opportunities

Discussion Draft of the
Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

Public Listening Session
Sept. 2 | 12 to 5 pm ET
Register Now >>

Written Comment Period
Sept. 1 - Sept. 4
More Information >>

Starting September 1, the National Academies will invite public comments on a Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, part of a study commissioned by NIH and CDC. The study will recommend priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic inequities and groups at higher risk due to health status, occupation, or living conditions.

Input from the public, especially communities highly impacted by COVID-19, is essential to produce a final report that is objective, balanced, and inclusive.

A discussion draft of the preliminary framework
will be available September 1. Prepare your comments now to help shape the final report.

Register Now! Public Listening Session

Wednesday, September 2 | 12:00 to 5:00 pm EDT

Please join us for an open session in which members of the public will be invited to address the study committee (as individuals or on behalf of an organization). You can sign up now to make a comment. However, because time at the session will be limited, we cannot guarantee that everyone will have the opportunity to make an oral comment. Please consider submitting a written comment between September 1 and September 4 (more information below).

Written Comment Period: September 1 - 4

Members of the public are encouraged to submit written comments for consideration by the study committee (as individuals or on behalf of an organization). The public comment period will be open for 4 days, from 12:00 p.m. ET on Tuesday, September 1, until 11:59 p.m. ET on Friday, September 4. Members of the public will be able to download and review the discussion draft before submitting a comment through a form (uploaded documents accepted). All materials comments received will be placed in the committee's Public Access File, and may be provided to the public upon request.

More Information

To learn more about the National Academies' study process, see Frequently Asked Questions on the project webpage.

Questions? Email COVIDVaccineFramework@NAS.edu

Help us spread the word!

Tweet this! | Public input, especially from groups highly impacted by #COVID19, is needed to inform a study on equitable vaccine allocation from @theNAMedicine & @theNASEM. Sign up now to make a comment at a 9/2 listening session with the study committee: https://bit.ly/3ln3xHr #vaccineframework

Tweet this! | When a #COVID19 vaccine is available, policymakers will have to make tough decisions about allocating the initial supply. On 9/2, @theNAMedicine & @theNASEM will host a listening session to hear comments from the public: https://bit.ly/3ln3xHr #vaccineframework

National Academies of Sciences, Engineering, and Medicine

View this email in your browser

Copyright © 2020 National Academy of Sciences, All rights reserved.

Our mailing address is:
500 Fifth Street NW
Washington, DC 20001

The Health and Medicine Division continues the consensus studies and convening activities previously undertaken by the Institute of Medicine (IOM). Visit us at http://nationalacademies.org/HMD